Table 2.

Prevalence of AMA1 antibodies seropositivity in children who never received SMC and children that SMC for 1, 2 and 3 years

	n	%	95% CI	Unadjusted			Adjusteda
				OR	95% CI	p	OR	95% CI	p
No SMC	154	97.5	95.0–99.9	Ref	–	–	Ref	–	–
SMC 1Y	263	97.0	95.1–99.1	0.85	0.25–2.88	0.79	1.18	0.34–4.07	0.79
SMC 2Y	226	97.4	95.4–99.5	0.97	0.27–3.52	0.97	1.45	0.39–5.37	0.58
SMC 3Y	218	94.4	91.4–97.4	0.43	0.13–1.36	0.15	0.66	0.21–2.15	0.49
SMC 1–3Y	707	96.3	94.9–97.6	0.68	0.23–1.97	0.47	0.99	0.33–2.97	0.99

SMC 1Y received SMC for 1 year, SMC 2Y received SMC for 2 years, SMC 3Y received SMC for 3 years, SMC 1–3Y received SMC for 1, 2, or 3 years

^aAdjusted for age, gender and malaria infection